Interaction networks, ecological stability, and collective antibiotic tolerance in polymicrobial infections

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 40, 2017, Pages 10666-10671

  De Vos, Marjon G J ^a,b   Zagorski, Marcin ^b   McNally, Alan ^c   Bollenbach, Tobias ^b,d  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antibiotics; Infection; Microbiology; Systems biology

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BACTERIUM ISOLATE; COMMUNITY CARE; DRUG TOLERANCE; ECOSYSTEM; HUMAN; MICROBIAL COMMUNITY; NONHUMAN; POPULATION DYNAMICS; PRIORITY JOURNAL; SPECIES DIVERSITY; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; FEMALE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MALE; MICROBIAL CONSORTIUM; MICROBIOLOGY;

BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL CONSORTIA; URINARY TRACT INFECTIONS;

EID: 85030449780     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1713372114     Document Type: Article

References (68)

1. Arndt WF, Ritts RE (1961) Synergism between staphylococci and proteus in mixed infection. Proc Soc Exp Biol Med 108:166–169.
2. Byrd AL, Segre JA (2016) Infectious disease. Adapting Koch’s postulates. Science 351: 224–226.
3. Peters BM, Jabra-Rizk MA, O’May GA, Costerton JW, Shirtliff ME (2012) Polymicrobial interactions: Impact on pathogenesis and human disease. Clin Microbiol Rev 25:193–213.
4. Short FL, Murdoch SL, Ryan RP (2014) Polybacterial human disease: The ills of social networking. Trends Microbiol 22:508–516.
5. Brogden KA, Guthmiller JM, Taylor CE (2005) Human polymicrobial infections. Lancet 365:253–255.
6. Croxall G, et al. (2011) Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 60:102–109.
7. Fredrickson AG, Stephanopoulos G (1981) Microbial competition. Science 213:972–979.
8. Wintermute EH, Silver PA (2010) Emergent cooperation in microbial metabolism. Mol Syst Biol 6:407.
9. Abrudan MI, et al. (2015) Socially mediated induction and suppression of antibiosis during bacterial coexistence. Proc Natl Acad Sci USA 112:11054–11059.
10. Riley MA, Wertz JE (2002) Bacteriocin diversity: Ecological and evolutionary perspectives. Biochimie 84:357–364.
11. Price-Whelan A, Dietrich LEP, Newman DK (2006) Rethinking ‘secondary’ metabolism: Physiological roles for phenazine antibiotics. Nat Chem Biol 2:71–78.
12. Andersen SB, Marvig RL, Molin S, Krogh Johansen H, Griffin AS (2015) Long-term social dynamics drive loss of function in pathogenic bacteria. Proc Natl Acad Sci USA 112:10756–10761.
13. Lee HH, Molla MN, Cantor CR, Collins JJ (2010) Bacterial charity work leads to population-wide resistance. Nature 467:82–85.
14. Yurtsev EA, Conwill A, Gore J (2016) Oscillatory dynamics in a bacterial cross-protection mutualism. Proc Natl Acad Sci USA 113:6236–6241.
15. Coyte KZ, Schluter J, Foster KR (2015) The ecology of the microbiome: Networks, competition, and stability. Science 350:663–666.
16. Widder S, et al.; Isaac Newton Institute Fellows (2016) Challenges in microbial ecology: Building predictive understanding of community function and dynamics. ISME J 10:2557–2568.
17. May RM (1973) Stability and complexity in model ecosystems (Princeton Univ Press, New York).
18. Alteri CJ, Himpsl SD, Mobley HLT (2015) Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLoS Pathog 11:e1004601.
19. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA (2012) The application of ecological theory toward an understanding of the human microbiome. Science 336:1255–1262.
20. Kelsic ED, Zhao J, Vetsigian K, Kishony R (2015) Counteraction of antibiotic production and degradation stabilizes microbial communities. Nature 521:516–519.
21. Czárán T, Hoekstra RF (2009) Microbial communication, cooperation and cheating: Quorum sensing drives the evolution of cooperation in bacteria. PLoS One 4:e6655.
22. Zhernakova A, et al.; LifeLines cohort study (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352:565–569.
23. Foster KR, Bell T (2012) Competition, not cooperation, dominates interactions among culturable microbial species. Curr Biol 22:1845–1850.
24. Vetsigian K, Jajoo R, Kishony R (2011) Structure and evolution of Streptomyces interaction networks in soil and in silico. PLoS Biol 9:e1001184.
25. Aguirre-von-Wobeser E, et al. (2014) Two-role model of an interaction network of free-living γ-proteobacteria from an oligotrophic environment. Environ Microbiol 16:1366–1377.
26. Pérez-Gutiérrez R-A, et al. (2013) Antagonism influences assembly of a Bacillus guild in a local community and is depicted as a food-chain network. ISME J 7:487–497.
27. Vega NM, Allison KR, Samuels AN, Klempner MS, Collins JJ (2013) Salmonella typhi-murium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci USA 110:14420–14425.
28. Yurtsev EA, Chao HX, Datta MS, Artemova T, Gore J (2013) Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol Syst Biol 9: 683.
29. Meredith HR, Srimani JK, Lee AJ, Lopatkin AJ, You L (2015) Collective antibiotic tolerance: Mechanisms, dynamics and intervention. Nat Chem Biol 11:182–188.
30. Gómez JM, Verdú M, Perfectti F (2010) Ecological interactions are evolutionarily conserved across the entire tree of life. Nature 465:918–921.
31. Hibbing ME, Fuqua C, Parsek MR, Peterson SB (2010) Bacterial competition: Surviving and thriving in the microbial jungle. Nat Rev Microbiol 8:15–25.
32. Macleod SM, Stickler DJ (2007) Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 56:1549–1557.
33. Darwin C (1859) On the origins of species by means of natural selection (Murray, London).
34. Burns JH, Strauss SY (2011) More closely related species are more ecologically similar in an experimental test. Proc Natl Acad Sci USA 108:5302–5307.
35. Fourcade C, Canini L, Lavigne J-P, Sotto A (2015) A comparison of monomicrobial versus polymicrobial Enterococcus faecalis bacteriuria in a French University Hospital. Eur J Clin Microbiol Infect Dis 34:1667–1673.
36. Chen SL, et al. (2013) Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med 5:184ra60.
37. Ives AR, Carpenter SR (2007) Stability and diversity of ecosystems. Science 317:58–62.
38. Gordon DM, Riley MA (1992) A theoretical and experimental analysis of bacterial growth in the bladder. Mol Microbiol 6:555–562.
39. Freter R, Brickner H, Botney M, Cleven D, Aranki A (1983) Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun 39:676–685.
40. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19:2803–2812.
41. Madersbacher S, et al. (2004) EAU 2004 guidelines on assessment, therapy and followup of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554.
42. Boscia JA, Kaye D (1987) Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1:893–905.
43. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13: 269–284.
44. Gleckman R, Blagg N, Joubert DW (1981) Trimethoprim: Mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications. Pharmacotherapy 1:14–20.
45. Hitchings GH (1973) Mechanism of action of trimethoprim-sulfamethoxazole. I. J Infect Dis 128:433–436.
46. McOsker CC, Fitzpatrick PM (1994) Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 33:23–30.
47. Bernier SP, Létoffé S, Delepierre M, Ghigo JM (2011) Biogenic ammonia modifies antibiotic resistance at a distance in physically separated bacteria. Mol Microbiol 81: 705–716.
48. Khanum N, et al. (2012) Influence of pH and temperature on stability of sulfame-thoxazole alone and in combination with trimethoprim (co trimoxazole). Asian J Chem 24:1851–1854.
49. Merton Boothe D (2015) Nitrofurans. Available at www.msdvetmanual.com/pharmacology/antibacterial-agents/nitrofurans. Accessed September 6, 2017.
50. Vega NM, Gore J (2014) Collective antibiotic resistance: Mechanisms and implications. Curr Opin Microbiol 21:28–34.
51. Brooks T, Keevil CW (1997) A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol 24:203–206.
52. Kommineni S, et al. (2015) Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 526:719–722.
53. Bouatra S, et al. (2013) The human urine metabolome. PLoS One 8:e73076.
54. Brunet YR, Espinosa L, Harchouni S, Mignot T, Cascales E (2013) Imaging type VI secretion-mediated bacterial killing. Cell Reports 3:36–41.
55. Momeni B, Xie L, Shou W (2017) Lotka-Volterra pairwise modeling fails to capture diverse pairwise microbial interactions. eLife 6:e25051.
56. Guo X, Boedicker JQ (2016) The contribution of high-order metabolic interactions to the global activity of a four-species microbial community. PLOS Comput Biol 12:e1005079.
57. Nielubowicz GR, Mobley HLT (2010) Host-pathogen interactions in urinary tract infection. Nat Rev Urol 7:430–441.
58. Kline KA, Fälker S, Dahlberg S, Normark S, Henriques-Normark B (2009) Bacterial adhesins in host-microbe interactions. Cell Host Microbe 5:580–592.
59. Blango MG, Mulvey MA (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54:1855–1863.
60. Stacy A, McNally L, Darch SE, Brown SP, Whiteley M (2016) The biogeography of polymicrobial infection. Nat Rev Microbiol 14:93–105.
61. Costello EK, et al. (2009) Bacterial community variation in human body habitats across space and time. Science 326:1694–1697.
62. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E (2010) The diagnosis of urinary tract infection: A systematic review. Dtsch Arztebl Int 107: 361–367.
63. Kim HJ, Boedicker JQ, Choi JW, Ismagilov RF (2008) Defined spatial structure stabilizes a synthetic multispecies bacterial community. Proc Natl Acad Sci USA 105: 18188–18193.
64. Lemonnier M, et al. (2008) The evolution of contact-dependent inhibition in non-growing populations of Escherichia coli. Proc Biol Sci 275:3–10.
65. Logan M, Higgins LM, Friedman J, Shen H, Gore J (2017) Co-occurring soil bacteria exhibit a robust competitive hierarchy and lack of non-transitive interactions. bioRxiv: 175737.
66. Balaban NQ, Gerdes K, Lewis K, McKinney JD (2013) A problem of persistence: Still more questions than answers? Nat Rev Microbiol 11:587–591.
67. Tsoularis A, Wallace J (2002) Analysis of logistic growth models. Math Biosci 179: 21–55.
68. Meyer PS, Ausubel JH (1999) Carrying capacity: A model with logistically varying limits. Technol Forecast Soc Change 61:209–214.